KineMed Presents Data Measuring Changes in Reverse Cholesterol Transport for the First Time
...approaches on RCT in real-time, in living animals. kinemed also presented data from its researchers and their...t and reverse atherosclerosis, thereby positioning kinemed as a leader in this field." RCT is one of the many pathways for which kinemed has the unique technology and IP to measure in int...KineMed to Present at the 4th Annual BIO Investor Forum
... EMERYVILLE, Calif., Oct. 8 /PRNewswire/ -- kinemed Inc., a privately held pathway-based drug discover...hat increase reverse cholesterol transport. About kinemed KineMed, Inc. ("KineMed" or the "Company") is a d...nd diseases of inflammation and neurodegeneration. kinemed is working to develop drugs both on its own and wi...KineMed to Collaborate With Merck KgaA to Validate New Applications for Drug Development Candidates
...ty in first-in-man studies. In the collaboration, kinemed will identify new therapeutic utility in in vivo p...rget is established for a selected drug candidate, kinemed and Merck KGaA will jointly determine the best dev... being studied. Under the terms of the agreement, kinemed will receive from Merck an upfront payment, milest...